Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Haemonetics Corp (NY: HAE )

86.97 -3.42 (-3.79%)
Streaming Delayed Price Updated: 2:33 PM EDT, Jul 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 172,705
Open 89.99
Bid (Size) 86.92 (2)
Ask (Size) 87.04 (2)
Prev. Close 90.39
Today's Range 86.94 - 91.29
52wk Range 70.74 - 97.97
Shares Outstanding 51,029,618
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NYSE:HAE stands out as a growth opportunity that won't break the bank.
NYSE:HAE is not too expensive for the growth it is showing. 
Via Chartmill
Looking for growth without the hefty price tag? Consider NYSE:HAE.
HAEMONETICS CORP/MASS (NYSE:HAE) stands out as a growth opportunity that won't break the bank. 
Via Chartmill

Performance

YTD
+2.14%
+2.14%
1 Month
+1.61%
+1.61%
3 Month
+2.46%
+2.46%
6 Month
+5.28%
+5.28%
1 Year
-5.13%
-5.13%

More News

Read More
Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst
Via Benzinga
This McCormick Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
These 3 Companies Boast Bright Outlooks
Via Talk Markets
NYSE:HAE, a growth stock which is not overvalued.
Via Chartmill
4 Analysts Assess Haemonetics: What You Need To Know
Via Benzinga
Earnings Scheduled For February 8, 2024
Via Benzinga
Is HAEMONETICS CORP/MASS (NYSE:HAE) suited for quality investing?
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024
Via InvestorPlace
For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.
Via Chartmill
Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
Via Investor's Business Daily
Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise
Via Investor's Business Daily
Exploring NYSE:HAE's quality characteristics.
Via Chartmill
Should you consider NYSE:HAE for quality investing?
Via Chartmill
4 Analysts Have This to Say About Haemonetics
Via Benzinga
Haemonetics Earnings Preview
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade
Via Investor's Business Daily
Haemonetics Corp. (NYSE: HAE) Making Surprising Moves in Monday Session
Via Investor Brand Network
Haemonetics Q4 Earnings Exceed Expectations On Volume And Price Benefits
Via Benzinga
Recap: Haemonetics Q4 Earnings
Via Benzinga
Looking Into Haemonetics's Return On Capital Employed
Via Benzinga
Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Wednesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.